ADCETRIS
Powder for concentrate for solution for infusion, 50mg
RxActive license
Active substance (INN)
brentuximab vedotin
Pharmaceutical form
Pharmaceutical formPowder for concentrate for solution for infusion
Strength50mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerTakeda Austria GmbH, Austria
Therapeutic groupAntineoplastic and immunomodulating agents (L01FX05)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateDecember 26, 2022
Source: CInMED register